SCHEMBL8479656

SCHEMBL8479656

O=[N+]([O-])c1cccc(Cl)c1-c1nc(-c2ccccn2)c(-c2ccc(Cl)cc2)[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 1/20 0.48
CYP2C9 P11712 1/20 0.48
MAPT P10636 3/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
RAB9A P51151 2/20 0.41
MAPK14 Q16539 8/20 0.41
MAPK13 O15264 7/20 0.41
MAPK12 P53778 7/20 0.41
MAPK11 Q15759 7/20 0.41
RAF1 P04049 1/20 0.41
GCGR P47871 6/20 0.40
CBFB Q13951 2/20 0.38
TEK Q02763 1/20 0.38
KDM4E B2RXH2 3/20 0.38
METAP1 P53582 2/20 0.38
ALDH1A1 P00352 2/20 0.38
NPC1 O15118 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
IDO1 P14902 1/20 0.37
MEN1 O00255 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6957125 0.84 MAPK14 (0.58) PTGESCYP2C9MAPTRAB9AMAPK14
SCHEMBL8482422 0.83 MAPT (0.42) MAPTL3MBTL1RAB9AMAPK14MAPK13
SCHEMBL8480021 0.82 MAPK13 (0.44) PTGESMAPTRAB9AMAPK14MAPK13
SCHEMBL8478420 0.79 MAPK14 (0.39) MAPTL3MBTL1RAB9AMAPK14MAPK13
SCHEMBL8476402 0.78 MAPK13 (0.47) MAPTL3MBTL1MAPK14MAPK13MAPK12
SCHEMBL8791036 0.76 MAPK14 (0.55) PTGESCYP2C9MAPTRAB9AMAPK14
SCHEMBL17002178 0.76 MAPK14 (0.63) CYP2C9MAPTRAB9AMAPK14MAPK13
SCHEMBL8793341 0.76 MAPK14 (0.63) CYP2C9MAPTRAB9AMAPK14MAPK13
SCHEMBL8481639 0.75 MAPK13 (0.44) L3MBTL1MAPK14MAPK13MAPK12MAPK11
SCHEMBL8791756 0.74 MAPK14 (0.55) PTGESCYP2C9MAPTRAB9AMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5959113-A REACTING A DIKETONE DERIVATIVE WITH AN ALDEHYDE DERIVATIVE; ADMINISTERING TO TREAT ATHEROSCLEROSIS, PSORIASIS, ALOPECIA AND TUMORS HOFFMANN-LA ROCHE INC. (US) 1999-09-28 US disclosed